Lead Sponsor

Abbott

Collaborators

Age

50 - No limit years

Sex

MALE

Healthy Volunteers

No

•Age \> 50 years
•Locally advanced (T3-T4) and/or metastatic (N+/M+) hormone-sensitive prostate cancer, confirmed by histological examination
•Presence of lower urinary tract symptoms (LUTS)-IPSS \>0
•Treatment with Lucrin® Depot is the routine therapy in the patient. The decision as to Lucrin® Depot choice will not be associated with patient's participation in the study, but will result from the best medical knowledge and practice.
•Until inclusion into PMOS the patient has not been treated with GnRH analogue.
•The patient, before inclusion into the study, has not been treated by surgery (radical prostatectomy).

•Patients will not be included into the study if any contraindications to treatment with Lucrin® Depot exist, or if there are other treatment options which, according to the present medical knowledge, are potentially more beneficial for the patient.
•Physician or patient can stop treatment at any moment, if any indications or reasons exist.